Why insider trading matters?
What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities approaches for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2021-03-10 | BEHRENS M KATHLEEN | Director | Sell | 5,000 | $85.76 | $428,800 | Yes |
| 2021-03-08 | Wigzell Hans Lennart Rudolf | Director | Sell | 10,000 | $83.51 | $835,100 | Yes |
| 2020-12-11 | Bratica Joseph | Principal Financial Officer | Sell | 1,115 | $165.00 | $183,975 | Yes |
| 2020-12-08 | Bratica Joseph | Principal Financial Officer | Sell | 1,125 | $160.00 | $180,000 | Yes |
| 2020-08-10 | Wigzell Hans Lennart Rudolf | Director | Sell | 10,000 | $159.00 | $1,590,044 | Yes |
| 2020-08-07 | Barry Richard | Director | Sell | 30,000 | $158.50 | $4,754,972 | No |
| 2020-08-03 | Bratica Joseph | Principal Financial Officer | Sell | 1,125 | $155.00 | $174,375 | Yes |
| 2020-06-22 | Howton David T | EVP, General Counsel | Sell | 105,122 | $170.88 | $17,962,831 | Yes |
| 2020-05-20 | Wigzell Hans Lennart Rudolf | Director | Sell | 5,000 | $150.64 | $753,210 | Yes |
| 2020-05-15 | Barry Richard | Director | Sell | 30,000 | $141.26 | $4,237,946 | No |
| 2020-03-04 | Wigzell Hans Lennart Rudolf | Director | Sell | 5,000 | $116.89 | $584,450 | Yes |
| 2019-12-13 | Cumbo Alexander | EVP, Chief Commercial Officer | Sell | 42,000 | $125.50 | $5,271,000 | Yes |
| 2019-12-13 | Howton David T | EVP, General Counsel | Sell | 78,000 | $125.50 | $9,789,000 | Yes |
| 2019-12-13 | Mahatme Sandesh | EVP, CFO & CBO | Sell | 125,000 | $125.50 | $15,687,500 | Yes |
| 2019-11-22 | Howton David T | EVP, General Counsel | Sell | 25,000 | $105.00 | $2,625,000 | Yes |
| 2019-09-13 | Barry Richard | Director | Buy | 5,000 | $87.49 | $437,455 | No |
| 2019-09-09 | BONNEY MICHAEL W | Director | Buy | 2,000 | $86.74 | $173,480 | No |
| 2019-09-06 | BEHRENS M KATHLEEN | Director | Buy | 2,500 | $87.98 | $219,950 | Yes |
| 2019-08-20 | Barry Richard | Director | Buy | 5,000 | $99.32 | $496,592 | No |
| 2019-08-14 | Barry Richard | Director | Buy | 3,700 | $122.50 | $453,250 | No |
| 2019-08-12 | Barry Richard | Director | Buy | 1,300 | $122.50 | $159,250 | No |
| 2019-08-12 | INGRAM DOUGLAS S | President & CEO | Buy | 16,252 | $123.07 | $2,000,160 | No |
| 2019-05-23 | Wigzell Hans Lennart Rudolf | Director | Sell | 10,000 | $120.00 | $1,200,000 | Yes |
| 2019-02-07 | Mahatme Sandesh | EVP, CFO & CBO | Sell | 65,000 | $145.00 | $9,425,000 | Yes |
| 2019-02-01 | Cumbo Alexander | SVP, Chief Commercial Officer | Sell | 15,000 | $140.00 | $2,100,000 | Yes |
| 2019-02-01 | Howton David T | SVP, General Counsel | Sell | 30,000 | $140.00 | $4,200,000 | Yes |
| 2019-01-31 | Mahatme Sandesh | EVP, CFO & CBO | Sell | 65,000 | $130.23 | $8,465,263 | Yes |
| 2018-11-01 | Wigzell Hans Lennart Rudolf | Director | Sell | 6,667 | $140.50 | $936,714 | Yes |
| 2018-10-31 | BEHRENS M KATHLEEN | Director | Sell | 10,000 | $131.71 | $1,317,100 | Yes |
| 2018-10-30 | INGRAM DOUGLAS S | President & CEO | Buy | 16,695 | $120.39 | $2,009,872 | No |
Insider Smart
Insider Smart